had sued a subsidiary of pfizer for illegal off-label promotion of a drug called neurontin. the attorney general did something interesting, the attorney general of all of the states decided to use some of the settlement money to fund educational initiatives for practitioners and consumers on inappropriate pharmaceutical marketing practices. i got one of those grants and in 2006 we started pharmedout at the georgetown university medical center. what we do is to promote rational prescribing and expose inappropriate marketing tactics. brian: are you for the doctors to use or for the patients to use? dr. fugh-berman: it is for the providers including nurses. but we also have fact sheets and information for consumers. brian: how do people get to that? dr. fugh-berman: pharmedout.org. brian: there is video on your website and i want to run some of it and have you explain it. the first thing is that anybody can see this, a drug rep talks and they are incognito. why is that? why did the drug rep not want to be known by their name? dr. fugh-berman: one of the thing that informs as we

- work on it at all during the time we were part of pfizer.nd when roger who is our -- a good friend and colleague and cofounder of esperion realized that pfizer was not working on it he saw an opportunity to get it back. and so pfizer effectively sold it back to the new esperion and we have been running with it ever since. >> well, this is babe ruth going from the red sox to the yankees and, you know, the red sox i think had a degree of remorse. tim, thank you so much. president and ceo of esperion. congratulations. you came on, you got a lot of people to buy who felt the power of your conviction and bought the stock. thank you for being on the show. >> thank you. >> okay. what can i say, esperion is not done. this drug going to be worth multiple billions. who am i to disagree? after the break i'll make your money. >>> coming up, on demand. starbucks announced a deal to bring fresh brew to your door. >> the delivery opportunity with postmates they have a significant national infrastructure. >> cramer talks to the man behind the superstar star

. >> pfizer have a pretty good day.effreys puts its on its franchise picks list. >> i love the stock. i don't think it's up today on the upgrade as much as the fact that a painkiller medicine has resumed phase three trials. they've got a breast cancer medicine that should hit the market in the second half of this year. it's probably a $5 billion medicine. >> speaking of franchising, pfizer peaks, you franchised pfizer a long time ago. >> love this name. i think this thing has nothing but upside. some of these names have made huge runs. you mention the breast cancer drug potential. i think this stock has plenty of upside still in front of it. >> do you differentiate between pfizer -- >> and merck -- i think they all sort of fall into very similar categoriries. when you look at what it's trading at on a pe ratio right now, that looks scary. they have this incredible pine line. and a lot of these names go into the generic area as well. huge upside. >> one extra thing about pfizer, they have the ceo who's probably going to

david: talk about another up thing, pfizer. pfizer is way up, over 3% today.> that's right, david. we saw with pfizer, a real winner on dow jones industrial average. new high for pfizer andly. because they collaborated on a pain medication that moving into further trials. that is good news. stock up 2 1/2%. cheryl: looking at herbalife. charlie gasparino, here last hour and that is the story the day. that stock is jumping. >> that may be a short squeeze. i is up 6.8%. we had a lot of nice winners, shake shack, gopro, herbalife. for losers we had winners to offset it. david: gold, what is happening there? >> up over five bucks. david: sounds good. >> not a big market day. [closing bell ringing]. not a big loss or win. kind of nice to see. david: exactly. we'll talk about politics, how ted cruz's plan to get rid of the irs might affect you. bells are ringing on wall street. look at all indices, basically flat on several of them, coming to the downside as we enter into settling of these marketings. when i came in it is up. now it is down. dow jones industrials do

pfizer asked the agency to drop the warning saying it didn't find difference in problems between peopleother drugs but fda says pfizer's research was too limited to draw reliable conclusions. >> the most expensive apple watch will cost $10,000. abc's america's money starts now. >> good morning, everybody. topping america's money details on the apple watch. it will go on sale april 24th with prices starting at about $350. >> but with the right wrist band and finish it could cost as much as $17,000. there are three basic models and preorders start april 10. at burg add burger king to the fast food chains dee emphasizing soda in kids meal. burger made the move following similar moves by mcdonald's and wendy's. >> beverage choices listed for kids milk, chocolate milk or juice. >>> the continuing sales slump after mcdonald's may push the burger giant to offer of all things kale. >> yum. >> at its restaurants. sales are off about 4 percent last month. that's more than expected. >> and the trendy menu item may make the restaurant seem more trendy. >> coming up at 5:30 new reaction from local s

there was a drug by pfizer a drug from lily, which is still being evaluated but the pfizer drug was abandoned and it's not quite clear why the biogen trial succeeded where these others have failed. there are a couple of possibilities. the first is that these biologicals can be different. one antibody made by one company may be slightly different from another in ways we may never even know. so it's possible that the biogen antibody is just superior to the others. it's also possible the biogen trial design was the secret because they screened for people who had-- they used amyloid brain scans to select the subjects. so they knew that the people going in had amyloid in their brain. in previous trials, those folks with amyloid negative or with negative amyloid scans were included. so if they were not responsive to the medication, they would have diluted out the effect. so it's possible that if these other drugs are tested with the same design, they might prove successful. >> sreenivasan: all right, samuel gandy alzheimer's researcher at mount sinai, thank you very much. >> thank you. >> sreenivas

cory: do you think selling data to pfizer will hurt the cousin now it will be a competitor and not just partner? jay: i don't think so. there are so many paths to success. it is unlikely whoever there customer would identify the same target and be competitive. cory: what is the hardest part for them starting this new venture? jay: i think it will be raising the money to support drug discovery. it's experience a important -- it is extremely important. this industry is unique in the world in that it takes between 10 and 12 years to target, to actually launch a product. it probably costs on the order of a billion dollars or more per product. 90% to 95% of the time, you fail along the way. you need capital to really drive the discovery forward. it's a challenge for anybody. we are in a good environment to raise money. they probably will raise the money but it will be ethical. cory: do they -- but it will be difficult. cory: do they think they will have a that her rate and a better speed-to-market as they know or they might know or they think they will know how the drugs will react before th

i think pfizer in the space is much more interesting at these levels. >>> all right. twitter topping the tape today surging 6% closing above $50 for the first time this year. does the social stock still have more room to run? we'll debate that. >>> netflix getting some love from two wall street firms. the company goes live in australia and new zealand. we'll tell you the best way to play the streaming space. >>> in one month, one month, the apple watch goes on sale. do you buy the stock now or wait to see if people buy the watch? we'll tell you how the stock usually trades around product releases coming up on "fast." friday night, buddy. you are gonna need a wingman. and my cash back keeps the party going. but my airline miles take it worldwide. [ male announcer ] it shouldn't be this hard. with creditcards.com, it's easy to search hundreds of cards and apply online. creditcards.com. >>> we got this whole thing all wrong. don't worry about declining commodity prices. in fact, my bottom line is that the lower >>> check out twitter's breakout topping the tape. shares of

they've been selling chunks of genetic data to pfizer and genentech and others but now they're doingt on their own. cory: do you think their business of selling to pfizer and the like will be hurt because they'll be a competitor and not just a partner? jay: i doubt it. there's so many paths to success and so many different targets, it seems unlikely that whoever their customer would identify the exact same target base odd then same genetics and then be competitive. cory: what is the hardest part for them do you think, starting this new venture? jay: i think it will be raising the money to support drug discovery. it's extremely important you know, this industry, i think, it's unique in the world in that it takes between 10 and 12 years from a target to actually launch a product probably costs on the order of $1 billion or more per product. and you know, 90 to 95% of the time you fail somewhere along the way. i think, you know aggregating the capital to really drive a discovery forward, you know, is a challenge for anybody. we're in a good environment, good marketplace to raise money f

bill: is it important to be as big as you might've been if you had been part of pfizer? -- pfizer?ood shape. we have come a long way as far as our scientific agenda. we had a very good 2014. we are optimistic about it and what it means to be an independent organization. stephanie: what is a strong dollar mean to you? paul: we will face headwinds globally, but we have allowed for that. like all organizations come -- organizations, we are watching it very closely. bill: biogen now has and also -- now has an alzheimer's drug. paul: anything that is good news for science in these patients, we want to be apart of. we have an awful lot going on it in type two diabetes, and oncology ourselves, targeted therapies, small molecules combinations. stephanie: what does obama care mean for you? paul: we are passionate about where the health care dollar get spent,. anything begets access to medicines as a patient is a good thing. we're trying to work with payers and providers to get the best value for the dollar. bill: i always wanted to ask this question -- how do you come up with the names for

a bigger boost for pfizer over the longer term. keep an i on pfizer, 2.5%.er note from raymond james. olivia has been following this one. alzheimer's drug treatment i don't know how to say the name of it. you want to buy generously on that drug because -- you want to buy jen worth -- genworth's option on it. assuming the biogen idec treatment is successful, this could be a way to get in on that. matt: everyone is hoping for the best. scarlet thank you. olivia: sometimes it seems the world is falling apart. we have real or geopolitical crises in ukraine, pakistan, and elsewhere. it is useful to take a look at the big picture over the next decade. i'm pleased to be joined by george friedman, joining us from his office in austin. his new book is flashpoints, the emerging crisis in europe. george, let's get right to it. you said the biggest risk in the next decade is the disintegration of russia. how do we get there you go -- how do we get there? george: the russian federation fell apart primarily because of economic failure and one of the major failures was the

it ordered pfizer to include warnings of the risk of seizure and users should cutback on alcohol whileing the drug. >>> some hospitals have higher survival rates than others when it comes to high risk surgeries. when it came to removing pancreases. one hospital had no deaths, while others had 19 out of 100 died. >>> a new drug that could be a game chaser in cosmetic procedures, is closer to reality. >> faculty from under the chin has to be removed by surgery or lipo suction. >>> a florida doctor said the injections are made in a grid pattern. it takes five minutes there's discomfort and bruising, but it is easier on patients than surgery. >> it's going to be noninvasive in the office procedure that can be performed by your determine oalings ologist and excellent results. >> reporter: the cell member britain of the fat cell is being damaged so that the cell exploits and goes away. >> the full fda is due to vote on it in late spring. once approved it could be available in the second half of the year. good morning, we are taking a live look right now as the procession for officer wilson b

we had a bullish call on pfizer this week. so it's not just bioteches. it's also more broadly pharmaceutical companies. >> pfizer since the acquisition, they seem to have their act together in terms of the stocks. just in terms of pete said now. we get a lot of pushback, biotech in a bubble. 35% have little or no earnings. i think we all understand that. but to pete's point, the main names that we speak about, the eight to ten names we talk about all the time on this show are very reasonably priced, have fantastic pipe lines, have great drugs out there. and all of them just about have unbelievable balance sheets as well. so great point on friday. we've seen action like this before in the ibb. i think it will last a couple more days but i think the bioteches are in a happy place. >> against that late february high of 2119 in the s&p, that's where the market topped out. we're within points of that today. people want to lock in their points. ibb up 20% year to date. where are you going to take the profits from? where you have the profits. >> what happens, t

last year pfizer asked the fda to drop the warning. >>> rain later this morning.mmute home. more rain friday into saturday. >> still keeping a close eye on the accident 29 southbound. sky 9 is there. we have two overturned vehicles. emergency crews are there on the scene as well. expect delays. if you're traveling on the outer loop of the beltway in college park, we're seeing volume delays there as well. >> cbs this morning is next. a convicted serial kill other death row reveal the location of his sixth victim. why did local law enforcement remove key information in the cases? ben tracy investigates. >> it's been called the greatest month in sports. before you fill out your ncaa bracket, cbs sports analyst jim nantz will be there to talk about march madness. go huskies is all i'm saying. don't forget our bracket challenge on wusa9. >> you could actually win some cash money on that one. any chili for me? >> there is plenty of chili. you missed the announcements. that's award winning right there. >> in between the chili, larry and i will be back in 25 with more tra

i was wonder about your opinion of buying pfizer. >> i thought would i never say this, but pfizer outrightght place to be. good yield. make you a lot of moves. smart, smart, smart. much smarter. and that ladies and gentlemen, is the conclusion of the lightning round. >> the lightning round is sponsored by td ameritrade. >> all right, cramer. what was up? if you have -- guess what we know what's happening. now think about it. this is exactly why we play. we got to stop this kind of thing. want you to call me and tell me your top five holdings. biotechs, that was wrong, right? i tell you if your portfolio is diversified. they're interested in selling. let's indulge in a tweet. @jenny lee part one. jim, love the show. jenny's in dominion _#mad tweets. thanks for helping the little guys. we are all it is guys. since i started the show i've shrunk an inch and a half. i'm literally a little guy. the restaurant group is cool because of sonic. wropt to be a buyer. celegene coming back to the sweet spot. 110, 112, intel, don't care for it. decent balance sheet, good yield. wells fargo is the number

a party but they did not do a sobriety test because they all were overruled by an on to the super pfizer creek-- on the supervisor. the two employees have been reassigned while home security well homeland's security investigate. >> pam: the new school test that parents were remade and take their children ability to succeed creek and the local correctional officer gives a gift of life to a coworker son we are live at the hospital next. >> pam: after months of calls for ferguson police chief to step down he is doing actually just that! in the wake of the justice report blistering report. >> reporter: stepping down, police chief in ferguson officially are resigned on march 19th. >> he no longer as has the ability to guide people into right direction because he has never been a true leader. >> reporter: rafting again after the city manager shaw has resigned after it >> this is on your watch this has happened on your watch and you need to clean house. >> reporter: of cess' of force targeting african- americans to receive e-mail to including one depicting president obama as a chimpanzee. jacks

companies from an array of industries such as apple, general electric and pfizer to bank of america andtarbucks briefed the court thursday. they're among the companies who say same-sex marriage is bad for business. the court will hear arguments in april. a decision is expected in june. >>> straight ahead, the girl scouts fight back. a troop sticks up for the workers who make their famous cookies after hearing about their working conditions. sir, we're going to need you on the runway later don't let a severe cold hold you back. get theraflu. it has the power of three medicines to take on your worst pain and fever, cough and nasal congestion. theraflu breaks you free from your toughest cold and flu symptoms. so you never miss a day. theraflu. serious power. get your family into kohls! and save storewide, starting friday! find polos in new spring colors from chaps 50% off. maiden form and warners bras only $19.99 each! refresh your bath towels with a color for everyone only $3.99 each! and upgrade your kitchen with kitchen aid! plus, pick up some kohls cash too. find great savings on great

that is if you get in on pfizer. interesting one, a twofer, raymond james recommending that investors purchase jen worth for an experimental alzheimer's drug. analysts they're called it a free option on the drug because about half of their long-term care insurance claims are alzheimer's or other forms of dementia. finally, gilead scientists having the worst day in two weeks after they issued a drug warning to health providers. apparently health -- nine patients developed abnormally slow heart beats and one patient died. the concern is that the warning could limit use of their drugs. analysts said that this would have a negligible commercial effect in terms of being a weakness as a buying opportunity. alix: all right, thank you so much. gerry fisher this year reaffirming what they said last year that a rate hike is likely before the end of the year but that the following increases will not be as protectable. >> beginning the normalization of policy will be a significant step towards the restoration of the economy's no

on the flip side a positive move for pfizer.to the franchise picks list at jeffries which raised its price target from $3 to $45. it says it expects pfizer shares to appreciate significantly in the next year or two on a fast lodge of its new breast cancer drug i brands. the groh of its established products and proteshl splitting off of that business in 2017. now, remember pfizer just spent about $16 billion to acquire hospira which jeffries expects to boost that established products unit. >> melissa, back to you. >> i think brian has a question meg. >> well it's sort of a question. i don't know if it's a question/comment. we were talking about it on friday. if you remember that guys about whether there's a bubble. these are the names that i have. we put it on the big screen. they were lower on the year ahead of today. a big reversal is my point for biotech today. >> there's definitely a question if a reversal is going to come. i've been talking a lot about folks about this and the fear about this and the sdugs about this is moun

think with a very important milestone in november of 2014 with entering this strategic alliance with pfizerur oncology pipeline. we are confident we will get products out of this pipeline in the next coming years. and so, it's one of our strategic projects going forward. >> marcus let's talk but the markets. the year 2016 could be the year of the cfo here in europe. the euro trading near a decade low. yields near record lows. let's talk about the currencies for now. though weaker euro, talk to me about strategy. >> obviously, on the first glance, the weak euro helps and when we translate currencies will simply more euro after that -- we simply have more euro left after that. on the other hand, in the long-term not only advantages would your operating or your currency has a weak value, you cannot be to have a weaker euro going forward. however in the short-term, it provides some tell wind. on the other hand, when you are a globally operating company, a little bit more diverse in a way we have definitely benefited from the u.s. dollar. at some of the important asian currencies like the taiwan

however a pfizer court ordered declassified leaving the door open for the program even if congress letshorization lapse area and jim harper joins me now. >> so explained section 215 of the patriot act. why is it so important to let this thing expire? >> 215 is the authority that the government uses in the foreign intelligence surveillance court. how long we are talking, who we are talking to, etc. this fisa court has indicated that if the 215 expires, the government has come up with a new explanation why they should be able to collect this information in that signals that the court will allow this. to the debate over this in congress and the public may not matter. the court could just allow them to continue collecting this information even if this authority goes away. kennedy: so people who actually care about this in this country, that infringes on our civil liberties as the government is in some cases illegally spying on american citizens, people should be concerned about this. my worry is that we are not talking about the nsa and that the government is spying on us as much as they sh

under my proposed amendment language, a drug company like pfizer, seeking to produce drugs utilizing a chemical subject to the advisory committee, could be excluded from participating as well. i think it would be highly unfair such as the university of florida could be excluded from an advisory activity and not a corporation like pfizer if there is reason to believe that it would be directly engage in activities utilizing the science upon which the board seeks to advise. clearly we must encourage the most qualified persons in various scientific fields to participate in the committees that compose the science advisory board. what we should not do, however is to allow persons to participate in advisory actions that may directly impact their own bottom lines. exist language in this bill, i believe, partially addresses our goal of preventing conflicts of interest, but accepting this grayson amendment would go much forward to accomplishing our common goal of preventing conflicts of interest and to that end i urge support of my amendment. i thank the chairman and i reserve the balance of m

today the food and drug administration said no and issued a new safety alert on the pill and warned pfizer of a risk of seizures and users should cut back on alcohol while taking the drug, the fda says they will not remove the black box warning until it sees the resultses of a study of psychological side effects. >>> and a push from capitol hill to remove rules against medical marijuana in states where it's already legal. ran paul joins two democratic senators including allows doctors and veterans to prescribe it. they hope to bring them up for a vote and admit it won't be easy to pass it. if you are still trying to catch up on the hour of sleep into daylight savings time you have a lot of company sleep experts say that a nap could help you recharge your energy if you do it right. you should only be napping 10 to 20 minutes so you don't go into a deep sleep that makes it harder to wake up and don't do it later in the day or you may have trouble doing it at night. studies show that naps could help you improve your mood. and by the way yesterday was national napping day and naps are benefici

pfizer, owned it forever, yield over 2% and up 11% year to date. more room to the upside. >> i'm melissa lee. thanks so much for watching. see you again at 5:00 for more f-fun. meantime don't go. mad mad. >>> my nation is simple. to make you money. i'm here to level the playing field for all investers. i promise to help you find it. mad money starts now. >>> hey welcome to mad money. well coming to cray america. i am just trying to save you some money. my job is to educate and teach you. call me or tweet me. we have things everywhere and the battlefield is in smoke. you can not tell who is winning the bulls or the bears. yet you know that on any good piece of news this market wants to go higher not lower. even as in the end we got handed a second straight hammering today. sop 4 ht 4 percent, nasdaq climbing point 26. what makes me say something positive after a house of pain? simple it's how they react to news and the pin action and news that impressed me. let me give you some real life battlefield commentary and you know why it's to the upside her

value, they just bought hispe rflt a. >> pfizer's innovating?r, a revolutionary immunooncology drug. in addition to financially innovating. >> yes, to lead the charge there. >> and i think biotech companies, like his sparian that have had great data come through. all of the companies this year that have done secondaries and done straight up radius health another one. development stage companies that have phase iii assets that have yet to be partnered, driving a lot of value. >> good to see you. >> great to see you. >> thank you for your time. barbara ryan from claremont partners. >> spiky today, david. you should go on vacation more often. wow. >>> coming up an update on the plane crash in europe and then an interview with a commerce secretary, penny pritzker. we'll be right back. now with the xfinity tv go app, you can watch live tv anytime. it's never been easier with so many networks all in one place. get live tv whenever you want. the xfinity tv go app. now with live tv on the go. enjoy over wifi or on verizon wireless 4g lte. plus enjoy spe

pfizer, ibm, exxonmobil, once again our newest member of the dow as of last week, apple, part of a partye dow. >>> all right, president obama had to make a very tough sell just moments ago. he's pitching foreign companies on investing in the united

fooiz pfizer is competing in the space. they're expected to talk about rejenner rons and amgen's next week. actelion will have a drug for pulmonary hypertension. celexopag will be on the market. the data we see over the weekend could have implications for both of those stocks. lots of activity in both drugs and medical devices at the cardiology conference. it's clearly hard at work on our heart. >> no one pronounces those drugs better than you do. >> i stay up at night. >> sarah, down to you. >> got a big story coming up. robert frank that sounds like a juicy one. >> sara this has everything an arrest in monaco secret storage bunkers, money laundering and billionaires who say they've been defrauded. it's tripping the art world coming up next. >>> welcome back to "power lunch." we want to draw your attention to the market. we are taking a look at the markets. the s&p down 21 points or 21%. the dow is down 1.25%. we are trying to bounce off of session lows. they're opening lower in the last few minutes here. also call your at

>> i think it might be redunn dan system i think merck or pfizer would be the next to go.placing them, both really good companies. just getting rid of redundancy, replacing it with amgen, roche, more of a biotech name to spread out diversification in the dow. liz: larry, i agree with you. that is interesting. we have big microsoft, cisco, intel names that, i wouldn't say they're redundant. but they're all technology. adam, what do you think? >> go with what the first guest said, you have to pick ge. even though a big market cap -- liz: you can't remove ge from the dow. >> right you can't lose at&t after 100 years. liz: there you are. >> ibm, despite they're trading $158 a share. because as the dow starts to shift to these new tech companies in this new economy started back in 1999, ibm is recreating itself. it become as software company. will not be able to compete with likes of google and apple. liz: i think travelers. i think travelers is vulnerable. it has $34 billion market cap and is 05 share price. that is my two cents. keeping your enemies close? amazon opening a st

they look at pfizer they're going to circle back to warren buffett-like names.'s not the end of the world. it's just kind of an okay tape. i still don't want to go -- if we see -- i'm going to reiterate, if we see celgene go higher -- >> the key to the market is celgene and it is up. >> there we go. lululemon, by the way, my people on the conference call they say west coast ports and weather, that's why the stock's knocked down four. >> west coast ports, sure of course that is lululemon. >> up 2%. >> bob pisani on what is moving. >> the close that we hit a few hours ago on the futures, we started down and moved even off of the lows from the start. let's put the s&p 500 up. we'll keep up the press conference. we're well off of that. it's interesting, energy is the leader here not surprise with oil stocks on the upside. tech is weak thanks to sandisk. health care industrials also a bit weak. but not that dramatically. there's also issues for stocks we've talked about the negative earnings growth. q1 being negative. and q2 have been negative. this is the fact for t

big call on pfizers. talking about manage care. >> they were talking about a new drug -- whenever i see these new drugs, an oncology franchise, that is post-menopausal, advanced breast cancer. i don't want to give people false hopes. but pfizer they're talking about a $13 billion franchise. that is huge. >> so many names on the move this morning here. let's give jim's brain a break here. >> no, i'm loving it! going back to pepsico. look at dupont. dupont said listen we're not putting health -- i find to have someone who is brilliant and provocative about the world in a changing world where it's -- greece, we haven't even mentioned greece. where it's mexico versus canada. >> where is your producer -- where is the idiot producer that put me on tv this morning. sally shin. what did i say we should talk about this morning? greece. >> producer? >> they said who's the idiot producer that put me on. >> very sweet girl. >> she's fantastic. >> hate to call her idiot. you think she doesn't take that personally? >>

but it's so important to millions of men and their partners, that i decided to talk -- >> pfizer hiredrmer presidential contender bob dole to be the face of viagra. but he did not just do viagra. he also did visa. and he did dunkin' donuts, and pepsi. once he did pepsi alone, and once he did pepsi with britney spears. he was the face of a lot of things after his presidential run. same thing with senator fred thompson from the great state of tennessee. senator thompson ran for president in 2008. he did unexpectedly poorly. lots of people thought that he would win the race overall. but he didn't win a single state, and he quit early, and somehow john mccain ended up winning the nomination. after that senator thompson went on to become the face of reverse mortgages. do you own your house, senior citizen? let me convince you to unown it for a cash payout. call now. it wasn't quite as exciting as watching britney spears dance around with bob dole on a recliner. but pays the bills. having a high political profile is a form of celebrity. and politicians do sometimes choose to trade on that fo

sponsored by pfizer. ges it's not likely to go away on its own. so let's do something about it.ides estrogens to help rebuild vaginal tissue and make intercourse more comfortable. premarin vaginal cream treats vaginal changes due to menopause and moderate-to-severe painful intercourse caused by these changes. don't use it if you've had unusual bleeding breast or uterine cancer blood clots, liver problems, stroke or heart attack, are allergic to any of its ingredients or think you're pregnant. side effects may include headache pelvic pain, breast pain vaginal bleeding and vaginitis. estrogens may increase your chances of getting cancer of the uterus, strokes, blood clots or dementia so use it for the shortest time based on goals and risks. estrogen should not be used to prevent heart disease heart attack, stroke or dementia. ask your doctor about premarin vaginal cream. ameriprise asked people a simple question: in retirement, will you have enough money to live life on your terms? i sure hope so. with healthcare costs, who knows. umm... everyone has retirement questions. so ameri

bristol trades 30 time forward earnings, twice as much as pfizer does.e an argument maybe they're deserved of it. many people anticipated a fast release, faster than it thought the fda would react. that's fine. you're getting into the deep end of the pool in bmy. a lot of analysts have 70 as their price target. >>> breaking news on a train derailment in illinois. morgan brennan has got the details. morgan? >> melissa, a bnsf train has derailed in illinois specifically galena, illinois. this train was carrying crude oil. just to give you some context here, galena, illinois, is just outside of dubuque, iowa, and three-hour drive from chicago. this is a 105-car train. 103 of those cars were filled with crude oil. see there the smoke coming from this train. local reports saying the train is on fire. bnsf putting out a statement just a short while ago, says the train derailed at approximately 1:20 central time. says there are no injuries and that respondents are en route. again, a bnsf train carrying crude oil has derailed in gal a galena, illinois. checking

expects they'll license the new drugs to establish companies rather than become a full drugmaker like pfizer glaxosmithkline. genentech is one of the three best bay area companies to work for. "fortune" says goingle is the best in the united states, google wins for the sixth year in a row. sales force number eight and genentech number nine. >>> stocks wednesday we couldn't keep it in the green. by now you can tell me why. we've been over this a lot of times. we need the fed to get on with it. >>> alibaba has become the latest investor in snapchat. the new investment gives snapchat a paper value of $15 billion. this first reported by the "wall street journal". guys t also makes snapchat one of the most valuable tech startups there is. tesla's worth 24 but it's tesla, they make cars, $24 billion. snapchat 15. >> they reach a lot of young people advertising. >> for sure. >> thank you very much, scott. >>> 5:53 right now. march madness, can you feel it? it is a productivity killer for companies. reportedly. >> a report by challenger, gray and christmas suggests distracted workers could cost empl

or perhaps a terrific drug company like pfizer that's been making fortunes with very big drugs untilrs bought more of the stocks and subsidized the losers with the sacrifice of winning stocks. let me give you the bottom line. get ready for the correction. it's coming. have some cash on hand. when it happens, don't sell the good ones to subsidize the bad. you'll end up with a terrible portfolio that won't be able to come back when times turn better. "mad money" is back after the break. ♪ building aircraft, the likes of which the world has never seen. this is what we do. ♪ that's the value of performance. northrop grumman. >>> favorite part of the special, we go for what you want. that's right. we got some tweets that you've been sending me @gym @jimcramer #madtweets. our first tweet, markrichard. take cash or buy selectively? your take. really easy call. a huge percentage of the gains that people have in the stock market over the years come exactly from dividend reinvestment. this is a no brainer and there are very few no brainers and very few free lunches in this business. compoundin

the key thing you know about activist, it's a growth plan that's not known by the same rules that pfizer or lily play for, which is why it rallied up $2.50 why the old line pharmas didn't do so hot. now, again, before this year before this year started, we didn't see this kind of disparity within various groups. it was very rare to see a biotech diverge from the older drug companies, it used to lead them up. but that's not the norm in 2015. we're back at that $43 level, where rich kinder the fave of kinder morgan came on our show and said there's actual demand that we could bounce. last time we bounced and bounced convincingly off this level and the oils rallied hard. investors were all over the oil stocks today betting that we could rebound again. if 2015 plays out as it has, though, i bet tomorrow is a different story. all of these trends and countertrends keep canceling each other out, causing the market to seem totally inconsistent. >> sell, sell, sell. >> buy, buy, buy. >> hey, look it continues after the close today, adobe, giant tech company reported a disappointing number, while

sponsored by pfizer. [ female announcer ] hands were made for talking. feet...tiptoeing.ings than the pain stiffness, and joint damage of moderate to severe rheumatoid arthritis. before you and your rheumatologist decide on a biologic ask if xeljanz is right for you. xeljanz (tofacitinib) is a small pill not an injection or infusion, for adults with moderate to severe ra for whom methotrexate did not work well. xeljanz can relieve ra symptoms, and help stop further joint damage. xeljanz can lower your ability to fight infections, including tuberculosis. serious, sometimes fatal infections and cancers have happened in patients taking xeljanz. don't start xeljanz if you have any infection unless ok with your doctor. tears in the stomach or intestines, low blood cell counts and higher liver tests and cholesterol levels have happened. your doctor should perform blood tests before you start and while taking xeljanz and routinely check certain liver tests. tell your doctor if you have been to a region where fungal infections are common, and if you have had tb, hepatitis b or c

take a look at big pharma names, bristol, merck, pfizer, and then take a look we talk about the biotechs the time, but big cap biotechs the move on a celgene and gill he adand amgen. all participating. not just the hospital stocks. nice move to the upside. i think there's plenty of upside. >> the smaller and mid cap biotechs that people continue to believe could be in a bubble? >> they're probably right on those, though, scott. people talk about bubbles in biotech you have to just look at it and say you can't make it about everything in biotech. >> i say small -- >> smaller one specifically. at the same time, those are the most exciting ones, most volatile, you want to trade. we talked about zio pharma not that long ago. the move that has made in the last week and a half or so. look at the volumes in some names as they get close to getting drugs to the market or potentially in front of the fda. you can see some of the dramatic moves you can get as well. >> joe? >> a premium being paid for growth and growth is found in the health care industry and not surprisingly enough and i don't know

he heads pfizer's vaccine operation. >> people haven't seen these diseases in a while, so people become complacent. they don't vaccinate. and what they wind up doing is putting their children and themselves in considerable risk of a severe disease and infection. polio, even though people aren't worried about it because they haven't seen much of it, is still present in many parts of the world, and it can easily be introduced into a non-vaccinated population. and from what we've seen in other parts of the world, once it's introduced, it will spread very rapidly and cause a lot of disease. >> the fear, my friends, is po lio. but soon, perhaps within a year, there may be a vaccine. >> thanks for visiting with us. hey, kids, how about saying good-bye, huh? >> good-bye! >> when i was a child and the big scare was polio, where you would see your friends playing ball outside with you, baseball and basketball, and all of a sudden get sick and be in bed, be in an iron lung, and then come out with a deformity, a serious limp, or a serious physical disability-- that is absolutely frozen in your min

pfizer, owned it forever, yield over 2% and up 11% year to date.e upside. >> i'm melissa lee. thanks so much for watching. see you again at 5:00 for more f-fun. meantime, don't go. m mad. >>> my nation is simple. to make you money. i'm here to level the playing field for all investers. i promise to help you find it. mad money starts now. >>> hey welcome to mad money. well coming to cray america. i am just trying to save you some money. my job is to educate and teach you. call me or tweet me. we have things everywhere and the battlefield is in smoke. you can not tell who is winning